ESR1 and cancer: Subsequent investigations were extended to ER-/PR-/AR+ cancer cell models, and demonstrated that AR signaling, induced by DHT, directly upregulates let-7a expression, which in turn reduces the levels of its target oncogenes CMYC and KRAS impairing cell proliferation (53).